Work

Evidence‐based update on Australasian pharmaceutical prescribing approaches for recurrent vulvovaginal candidiasis

Year: 2021

Type: article

Abstract: Recurrent vulvovaginal candidiasis (RVVC) is a subtype of vulvovaginal candidiasis, with debilitating effects on physical and emotional well-being affecting up to 10% of Australian women. Current evidence suggests that the induction and maintenance approach for RVVC is not particularly effective with post-treatment relapse rates as high as 57%. Frequently accessed Australasian RVVC prescribing resources and guidelines were examined showing a variety of adaptations of current evidence-based induction and maintenance therapies, making it difficult to select best treatment in clinical practice. The ways to introduce more clarity and consistency into these guidelines are outlined.

Source: Australian and New Zealand Journal of Obstetrics and Gynaecology

DOI: 10.1111/ajo.13376

Authors: Moira Bradfield Strydom, Ramesh Lahiru Walpola, Sohil Khan, Robert S. Ware, Evelin Tiralongo

Institutions: Griffith University, UNSW Sydney

Language: English

Topic: Reproductive tract infections research

Subfield: Microbiology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W3165658062

FWCI: 0.792

Cites: 18

Cited by: 5

Related to: 10